|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.55 EUR | -0.89% |
|
+2.78% | +23.33% |
| May. 01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
| Mar. 28 | Transcript : Malin Corporation plc - Shareholder/Analyst Call |
Malin Corporation plc reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net income was EUR 12.9 million compared to EUR 37.8 million a year ago. Basic earnings per share from continuing operations was EUR 0.38.
Diluted earnings per share from continuing operations was EUR 0.38. Basic earnings per share was EUR 0.38 compared to EUR 0.85 a year ago. Diluted earnings per share was EUR 0.38 compared to EUR 0.85 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.33% | 114M | |
| +32.70% | 690B | |
| +26.43% | 546B | |
| -4.87% | 358B | |
| +18.16% | 323B | |
| +4.93% | 287B | |
| +14.17% | 235B | |
| +5.67% | 199B | |
| -9.49% | 195B | |
| +4.60% | 161B |
MALIN CORPORATION PLC 